Industry Leaders
-
Beyond Capital and Mentoring: Paving The Way For Female Entrepreneurs
1/2/2019
Women who are starting life sciences companies often do not have access to a network of mentors and advisors, whose strong advocacy establishes instant credibility and opens the doors to investors.
-
Why Soft Skills Are The Key To Better Science And Collaborations
8/2/2018
Here are some examples of why “soft skills,” such as those related to relationship building, leadership, and communication, are essential to today’s pharma and biotech leaders.
-
As Pediatric Rare Disease Patients Grow Up, Can We Keep Pace?
8/2/2018
Companies frequently talk about being patient-centric. But what I don’t hear discussed as often is the role of the patient after a drug is approved. And I am convinced it is equally important. Why? Because patients are not static; they grow and change over time.
-
Cell And Gene Therapies: Driving Innovation For Logistical Solutions
4/6/2018
Aside from the clinical opportunity that gene therapy products present; they do introduce tremendous complexity into both the manufacturing and commercial processes. Remember these three points before developing your gene therapy plan.
-
Is Your Lab Prepared For A Cybersecurity Attack?
2/7/2018
While the costs and reputational implications associated with pharma data breaches are enough to pay heed to cybersecurity, these compromises can pose a serious threat to patient safety.
-
Classifying Independent Contractors: 3 Things Pharma CEOs Should Know
1/9/2018
Similar to a clinical trial setback, misclassification of independent contractors (ICs) can have a substantial negative impact on a pharma business.
-
In M&A, The Devil's In The Details ... Of Your Insurance Policy
1/9/2018
Pharma companies that don’t emphasize risk management and insurance due diligence while adding exposures from new products or services to their policies will see the far-reaching impacts on their budgets.
-
Research Reveals Critical Need To Eliminate Clinical Silos
9/8/2017
New research confirms that many of the challenges sponsors face managing clinical trials stem from the disparate nature of processes and systems.
-
5 Areas To Focus On To Improve Drug Development Productivity
7/7/2017
Much has been written about opportunities for improving the drug development process. Although there are many areas ripe for process improvements, let’s focus on the following five.
-
Personalizing The Work Of Life Sciences Organizations
7/7/2017
Many parents can tell a story about the lengths they’ve gone to help their children when no doctor could provide an answer. But there’s one story that stands out to me above the rest because it really drives home the vital need for data sharing, digital collaboration, and the establishment of a connected health ecosystem in the life sciences industry.